Litcius/Paper detail

Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial

David M. Pariser, Jerry Bagel, Mark Lebwohl, Gil Yosipovitch, Elaine Chien, Mary Spellman

2020Journal of the American Academy of Dermatology47 citationsDOI

Topics & Concepts

MedicineDouble blindPlaceboDermatologyRandomized controlled trialClinical trialInternal medicineAlternative medicinePathologyPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesSpondyloarthritis Studies and Treatments
Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial | Litcius